A Lakshman Rekha in pharma FDI
Policy makers in India need to adapt fast to new realities and move forward like other global regulators
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Proparco invests in Strides’ African arm
Funding to build additional manufacturing infrastructure in key markets in Africa
Pharmexcil to host Japanese delegation
To conduct meetings at New Delhi and Mumbai on July 26 and 27
US FDA: More than 150 ARVs available through PEPFAR for worldwide HIV/AIDS relief
Four Indian companies (Cipla, Hetero Labs, Micro Labs, Edict Pharmaceuticals) are the most recent to receive tentative approvals…
EU Commission proposes revamp of clinical trial rules
Move aimed at boosting clinical research in EU
Thermo Fisher Scientific releases whitepaper on LC/MS instruments
LC/MS Solvent Range provides highest purity with low background noise and metal ion content
Aurobindo Pharma receives US FDA nod
To manufacture and market Metformin Hydrochloride Extended-Release (ER) tabs
Founder of Glenmark Pharma passes away
Gracias Saldanha had retired as Chairman and Non-Executive Director in 2011
Taro’s Special Committee rejects proposal from Sun Pharma
Offer deemed "inadequate, not in the best interests of Taro’s minority shareholders"
DNDi and Cipla to develop antiretroviral drug combination
New formulation to provide appropriate HIV medicines for infants and young children